Cargando…
Rapid generation of Col7a1(−/−) mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells
Recessive dystrophic epidermolysis bullosa (RDEB) is a debilitating and ultimately lethal blistering disease caused by mutations to the Col7a1(−/−) gene. Development of novel cell therapies for the treatment of RDEB would be fostered by having immunodeficient mouse models able to accept human cell g...
Autores principales: | Webber, Beau R., O’Connor, Kyle T., McElmurry, Ron T., Durgin, Elise N., Eide, Cindy, Lees, Christopher J., Riddle, Megan J., Mathews, Wendy, Frank, Natasha Y., Kluth, Mark A., Ganss, Christoph, Moriarity, Branden S., Frank, Markus H., Osborn, Mark J., Tolar, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623156/ https://www.ncbi.nlm.nih.gov/pubmed/28892093 http://dx.doi.org/10.1038/labinvest.2017.85 |
Ejemplares similares
-
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa
por: Webber, Beau R, et al.
Publicado: (2016) -
Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa
por: Tolar, Jakub, et al.
Publicado: (2013) -
Advances in understanding and treating dystrophic epidermolysis bullosa
por: Vanden Oever, Michael J, et al.
Publicado: (2014) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014) -
Clinical trial of ABCB5(+) mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
por: Kiritsi, Dimitra, et al.
Publicado: (2021)